HIV Counseling Intervention for Methadone-Maintained Patients - 2
Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on December 31, 2007
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Opioid-Related Disorders
Intervention: Behavior Therapy (Behavioral)
Phase: Phase 1
Status: Active, not recruiting
Sponsored by: National Institute on Drug Abuse (NIDA) Official(s) and/or principal investigator(s):
Frances R Levin, M.D., Principal Investigator, Affiliation: Research Foundation for Mental Hygiene, Inc.
Summary
The purpose of this study is to evaluate HIV counseling intervention for Methadone-Maintained
Patients.
Clinical Details
Official title: HIV Counseling Intervention for Methadone-Maintained Patients
Study design: Prevention, Randomized
Primary outcome: AIDS risk behavior
Detailed description:
The purpose of this proposal is to evaluate, in methadone-maintained patients the association
between an ADHD diagnosis and high-risk HIV/Hepatitis behavior. In addition, we would like to
determine whether a new manually-guided HIV intervention; RISE: Reduce high risk Intravenous
drug use and unsafe Sexual Encounters is superior to standard HIV/Hepatitis
psycho-education.
Eligibility
Minimum age: 18 Years.
Maximum age: 60 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
Must meet DSM-IV criteria for opiate dependence and currently in methadone maintenance
treatment
Able to give informed consent and capable of complying with study procedures
Women who are of childbearing age and/or pregnant may be included
Individuals who are HIV-positive or have Acquired Immunodeficiency Syndrome may be
included
Patients who demonstrate moderate to high HIV risk behaviors will be included
Patients with low to no HIV risk behaviors will be excluded
Patients receiving a stable dose of methadone for three weeks will be included
Exclusion Criteria:
Currently meets DSM-IV criteria for current Axis I psychiatric disorders (other than ADHD
or substance abuse) which requires medical intervention, i. e., active suicide ideation,
active psychosis, anxiety disorders, depression requiring hospitalization
Patients who have exhibited suicidal or homicidal behavior within the past two years
HIV positive patients must have knowledge of their status for a minimum of three weeks
Locations and Contacts
Research Foundation for Mental Hygiene, Inc., New York, New York 10032, United States
Additional Information
Starting date: October 1999
Last updated: November 3, 2005
|
